The generic name for Besivance is besifloxacin [1].
What is besifloxacin used for?
Besifloxacin is a topical ophthalmic fluoroquinolone antibiotic used to treat bacterial conjunctivitis [1]. It is available in a 0.6% ophthalmic suspension [1].
How does besifloxacin work?
Besifloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, repair, and recombination [2]. This action leads to the death of susceptible bacteria [2].
When does the patent for Besivance expire?
Information on the specific patent expiry for Besivance is not readily available in the provided text. DrugPatentWatch.com tracks patent information for pharmaceuticals [3].
Are there other fluoroquinolone eye drops?
Yes, other fluoroquinolone antibiotics used in ophthalmic preparations include ciprofloxacin, levofloxacin, moxifloxacin, and ofloxacin [4]. These medications are also used to treat bacterial eye infections [4].
What are the potential side effects of besifloxacin?
Common side effects of besifloxacin eye drops may include blurred vision, eye irritation, and a bitter taste [1]. More serious side effects, though less common, can include allergic reactions [1].
Who manufactures Besivance?
Bausch & Lomb developed and markets Besivance [1].
How is besifloxacin administered?
Besifloxacin is administered as eye drops. The typical dosage is one drop instilled into the affected eye(s) two to three times daily for seven days [1].
*
**Sources:
1. https://www.drugpatentwatch.com/drug/besivance
2. https://www.drugpatentwatch.com/drug/besifloxacin
3. https://www.drugpatentwatch.com/
4. https://www.drugpatentwatch.com/drug-class/fluoroquinolone-ophthalmic-antibiotics